Epidemiology of sepsis in Victoria, Australia
- 1 January 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 33 (1) , 71-80
- https://doi.org/10.1097/01.ccm.0000150027.98160.80
Abstract
To determine the clinical and epidemiologic characteristics of patients with sepsis admitted to hospitals in Victoria, Australia, including the incidence of sepsis and severe sepsis, utilization of intensive care unit (ICU) resources, and hospital mortality. A population-based hospital morbidity database generated from hospital discharge coding. State of Victoria, Australia (population, 4.5 million), the 4-yr period from July 1, 1999, to June 30, 2003. A total of 3,122,515 overnight hospitalizations. None. The overall hospital incidence of sepsis was 1.1%, with a mortality of 18.4%. Of septic patients, 23.8% received some care in an ICU. For these patients, hospital mortality was 28.9%. Severe sepsis, defined by sepsis and at least one organ dysfunction, occurred in 39% of sepsis patients and was accompanied by a hospital mortality of 31.1%. Fifty percent of patients with severe sepsis received at least some care in an ICU. Australian state hospital administrative data reveal epidemiologic features of sepsis and severe sepsis that are strikingly similar to those recently reported from comparable populations in North American and Europe. This suggests that lessons learned in this area may be directly applicable internationally.Keywords
This publication has 14 references indexed in Scilit:
- Adult-population incidence of severe sepsis in Australian and New Zealand intensive care unitsIntensive Care Medicine, 2004
- Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern IrelandCritical Care Medicine, 2003
- Influence of Systemic Inflammatory Response Syndrome and Sepsis on Outcome of Critically Ill Infected PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2003
- The Epidemiology of Sepsis in the United States from 1979 through 2000New England Journal of Medicine, 2003
- Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis*Critical Care Medicine, 2003
- Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort studyIntensive Care Medicine, 2001
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- Epidemiology of Sepsis Syndrome in 8 Academic Medical CentersJAMA, 1997
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992